| LONZA GROUP AG NA SF 1 |
| Schweiz |
| Gesundheit |
| CH0013841017 / 928619 |
| LO3 (Frankfurt) |
| FRA:LO3, ETR:LO3, LO3:GR |
| SMI |
| https://www.lonza.com/ |
|
Lonza Group AG is a Swiss-based global leader in contract development and manufacturing organization (CDMO) services for the pharmaceutical, biotech, and nutrition industries. Founded in 1897, it has evolved from electrochemical manufacturing and pow..
>Volltext.. |
| 37453.93 Mio. EUR |
| 41529.88 Mio. EUR |
| 7055.01 Mio. EUR |
| 2229.6 Mio. EUR |
| -297.06 Mio. EUR |
| -4.24 EUR |
| 4867.53 Mio. EUR |
| 776.69 Mio. EUR |
| 1262.79 Mio. EUR |
| 0.2 |
| 0.31% |
| -143.66% |
| 2.16 EUR |
| 0.78% |
| 0.97% |
| 13.05.25 - 2.1622€ 13.05.24 - 4.3244€ >weitere anzeigen... |
| - |
| LONZA |
| 08.04.26 |
|